FIELD: medicine, biochemistry.
SUBSTANCE: invention relates to the development of a method for inhibition of inflammation by providing cell with monoterpene compositions that inhibit activity of factor NF-kB. These compositions can comprise also a moiety as a carrier that provides membrane-permeable properties for monoterpene composition. A carrier can comprise triterpenoid moieties, sugars, lipids or even additional monoterpenoid moieties. Composition can comprise additional chemical functional agents. Invention provides enhancing effectiveness in treatment of inflammatory states, in particular, precancer states.
EFFECT: valuable medicinal properties of compositions.
54 cl, 55 tbl, 62 dwg, 48 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRITERPENE COMPOSITIONS AND METHODS FOR THEIR APPLYING | 1999 |
|
RU2244547C2 |
| METHOD OF INHIBITING KAPPA NUCLEAR FACTOR WITH THE USE OF POTASSIUM 5-HYDROXYNICOTINATE IN A CELL CULTURE | 2017 |
|
RU2675693C1 |
| AGENT STIMULATING APOPTOSIS OF HUMAN LEUKAEMIA CELLS | 2007 |
|
RU2360692C1 |
| METHOD FOR INHIBITING NUCLEAR FACTOR KAPPA B WITH USE OF 5-HYDROXYNICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE IN CELL CULTURE | 2017 |
|
RU2674443C1 |
| METHOD FOR INHIBITING NUCLEAR KAPPA B FACTOR WITH USING 2-ETHYL-6-METHYL-3-HYDROXIPIRIDINIUM L-2,6-DIAMINOHEXANOATE IN CULTURE OF CELLS | 2017 |
|
RU2669348C1 |
| METHOD OF STIMULATION OF HUMORAL AND CELLULAR IMMUNITY RESPONSE TO TARGET ANTIGEN | 1996 |
|
RU2127605C1 |
| COMBINATION OF ANTIBODY HAVING SELECTIVITY IN RELATES TO APOPTOSIS INDUCING LIGAND RECEPTOR ASSOCIATED WITH TUMOR NECROSIS FACTOR AND OTHER THERAPEUTIC AGENTS | 2002 |
|
RU2313368C2 |
| INDUCTION OF APOPTOSIS IN TUMOUR CELLS, EXPRESSING TOLL-LIKE RECEPTOR | 2005 |
|
RU2401661C9 |
| TEST SYSTEM FOR ANALYSING FUNCTIONAL ACTIVITY OF ANTIBODIES AGAINST PD-1 AND ANTIBODIES AGAINST PD-L1 | 2019 |
|
RU2731896C1 |
| METHOD FOR OBTAINING FRONDOSIDE A AND METHOD OF IMMUNE SYSTEM STIMULATION FOR MAMMALS | 2005 |
|
RU2339644C2 |
